- Home
- HBNC vs IDYA Comparison
HBNC vs IDYA Comparison
Compare HBNC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- IDYA
- Stock Information
- Founded
- HBNC 1873
- IDYA 2015
- Country
- HBNC United States
- IDYA United States
- Employees
- HBNC N/A
- IDYA N/A
- Industry
- HBNC Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- HBNC Finance
- IDYA Health Care
- Exchange
- HBNC Nasdaq
- IDYA Nasdaq
- Market Cap
- HBNC 678.2M
- IDYA 1.9B
- IPO Year
- HBNC N/A
- IDYA 2019
- Fundamental
- Price
- HBNC $15.75
- IDYA $22.69
- Analyst Decision
- HBNC Hold
- IDYA Buy
- Analyst Count
- HBNC 2
- IDYA 12
- Target Price
- HBNC $17.00
- IDYA $50.82
- AVG Volume (30 Days)
- HBNC 167.1K
- IDYA 1.0M
- Earning Date
- HBNC 07-23-2025
- IDYA 08-05-2025
- Dividend Yield
- HBNC 4.01%
- IDYA N/A
- EPS Growth
- HBNC 88.54
- IDYA N/A
- EPS
- HBNC 1.02
- IDYA N/A
- Revenue
- HBNC $201,164,000.00
- IDYA $7,000,000.00
- Revenue This Year
- HBNC $46.44
- IDYA $101.20
- Revenue Next Year
- HBNC $4.83
- IDYA $286.70
- P/E Ratio
- HBNC $15.41
- IDYA N/A
- Revenue Growth
- HBNC 11.46
- IDYA N/A
- 52 Week Low
- HBNC $12.70
- IDYA $13.45
- 52 Week High
- HBNC $19.18
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- HBNC 56.01
- IDYA 59.61
- Support Level
- HBNC $15.71
- IDYA $20.99
- Resistance Level
- HBNC $16.49
- IDYA $23.06
- Average True Range (ATR)
- HBNC 0.41
- IDYA 0.94
- MACD
- HBNC 0.04
- IDYA 0.01
- Stochastic Oscillator
- HBNC 63.68
- IDYA 85.55
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.